With pivotal trial underway, Ionis ramps up Angelman syndrome awareness with Lifetime TV segment

17th December 2025 Uncategorised 0

After spending the last decade developing the drug known as ION582 and building relationships with the Angelman syndrome community, Ionis is now expanding that outreach work to include awareness-raising efforts for a broader audience.

More: With pivotal trial underway, Ionis ramps up Angelman syndrome awareness with Lifetime TV segment
Source: fierce